Recognizing these global disparities, ASCO recently created tiered treatment guidelines specifically for the management and care of women with invasive cervical cancer, stratified by availability of ...

Endometrial carcinoma is the most frequent gynecological cancer. The disease-related death rate in FIGO stage II–IV is high (20–80% and higher), while in the ‘favorable’ early stage FIGO I, the death ...

image: Kaplan-Meier overall survival curves for 62 uterine cervical neuroendocrine carcinoma patients according to FIGO stage. Advanced FIGO staging disease (III, IV) patients (n = 6) showed ...

Among patients with FIGO 2014 Stage III-IVA cervical cancer, treatment with pembrolizumab plus CRT significantly reduced the risk of disease progression or death by 41% compared with placebo plus CRT.

Uterine leiomyosarcoma (LMS) is staged by the modified International Federation of Gynecology and Obstetrics (FIGO) staging system for uterine cancer. We aimed to determine whether the American Joint ...

Approval is based on the results from phase III KEYNOTE-A18/ENGOT-cx11/GOG-3047 2 The trial enrolled 1,060 newly diagnosed patients with locally advanced squamous ...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti ...

Nomograms are predictive tools that are widely used for estimating cancer prognosis. The aim of this study was to develop a nomogram for the prediction of overall survival (OS) in patients diagnosed ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. “One of the major challenges faced by clinicians is to ...